PEX sp. z o.o.

Market research and public opinion polling

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-10-29
Share capital
12,200,000.00 PLN
Average employment (people)
41 (2025)
Activity description

PEX sp. z o.o. is an advisory and research company operating in the Polish healthcare and pharmaceutical market. It provides pharmacy data from a panel covering over 50% of pharmacies in Poland, along with market analyses, research, forecasts and consulting, including Market Access projects. The company is a subsidiary of KAMSOFT S.A. and employs a team of about 80 experts.

Registered address
ul. Migdałowa 4D/46, 02-796 Warszawa, Poland
Website
Phone
Social media
Electronic delivery address
AE:PL-47153-90072-GTGUA-31

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$233,492
Profit allocationCovers prior losses
Capital expenditure$118,573
Planned capital expenditure (next year)$100,452
Foreign sales1.14% of revenue ($104,616)
Revenue structuresyndykatowe analizy danych

Filing timeliness

Financial statements were filed on time, on average 73 days early. 3 of 6 audited by a statutory auditor.

  • 202516/04/2026
  • 202424/03/2025
  • 202327/06/2024
  • 202228/06/2023
  • 202105/05/2022
  • 202009/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 3.8%
Top 2.5%
City · Warszawa3,919 / 56,772
Top 6.9%
Voivodeship · Mazowieckie5,483 / 76,953
Top 7.1%
Country · Poland19,989 / 297,266
Top 6.7%

Results vs industry

Revenue
This companyUSD 9.60mMedianUSD 112.93kAverageUSD 1.39m
Net profit
This companyUSD 981.44kMedianUSD 3.34kAverageUSD 117.93k
Operating costs
This companyUSD 8.32mMedianUSD 100.06kAverageUSD 1.26m
Assets
This companyUSD 5.68mMedianUSD 91.62kAverageUSD 1.28m

Offer

  • Pharmaceutical market research
  • Pharmacy data analyses
  • Market forecasts
  • Consulting for the pharmaceutical industry
  • Market Access services

Websites

The site is available in: Polish and English.

  • pexps.plPEX – Twój partner biznesowy na rynku farmaceutycznym
    WordPress 7.1ElementorGoogle AnalyticsGoogle Tag ManagerRank MathPolylangCloudflareLiteSpeed

Trademarks

The company holds 13 active trademarks registered with the Polish Patent Office. 6 marks have expired or were not registered. The first mark was filed in 1998.

MarkNumberClassesStatusProtected until
Forecaster PEX (word)Z.58482835Protected May 16, 2035
Profiler PEX (word)Z.58481835Protected May 16, 2035
Prognozer PEX (word)Z.58482435Protected May 16, 2035
PEXmind (word)Z.57972535Protected Jan 27, 2035
Launcher (word)Z.57972335Protected Jan 27, 2035
MarkProtected until
Forecaster PEX (word)May 16, 2035
Profiler PEX (word)May 16, 2035
Prognozer PEX (word)May 16, 2035
PEXmind (word)Jan 27, 2035
Launcher (word)Jan 27, 2035

Authorized Representatives

Jakub Edward Dalach age 52 – President of the Management Board
Edyta Natalia Zagrajek-Słyk age 37 – Vice President of the Management Board
Grzegorz Jan Mródź age 53 – Attorney-in-fact (sole)

Manner of representation

Each member of the management board has the right to represent the company independently

Ownership

OwnerSharesShare valueStake
24,400$3,295,515.94100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-10-29.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$20,888
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$19,271
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$18,817

Competitors

Name
Kantar Polska S.A.
Ipsos sp. z o.o.
Minds&Roses sp. z o.o.
Biostat sp. z o.o.
Opinia24 sp. z o.o.
PBS sp. z o.o.
IQS sp. z o.o.
Danae sp. z o.o.
Zymetria sp. z o.o.
ARC Rynek i Opinia sp. z o.o.

Change history

DateEvent
2024-01-03Name change
2022-09-14Address change
2021-02-25Share capital increase
2020-01-29Share capital increase
2017-11-21Address change

FAQ

Last updated: 2026-10-07